IsoPlexis Proteomic Product Suite for Oncology & Tumor Functional Phenotyping

Learn how IsoPlexis’ Functional Proteomics reveals unique multi-omic signatures and insights into oncology.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

Resolving tumor heterogeneity to reveal independent trajectories of drug tolerance
Informing targeted combination therapy to overcome resistance with single-cell intracellular proteomics
Understanding cancer cell communication to infer a strategy to inhibit tumor cell metastasis
Revealing aberrant cytokine signatures of progenitor myeloid cells in disease progression in mice
A Deeper Look

More about this

Overcoming Challenges in Oncology

Cancer cells in the tumor microenvironment secrete cytokines that interact with other cells, such as immune cells, in a 3D extracellular matrix, which facilitates intracellular communications and jointly moderates pathophysiological processes, including cancer-induced angiogenesis and metastasis.

Download this App Note to learn how IsoPlexis detects the key intracellular pathways in tumor cells to help you understand earlier in development the impacts of your therapies and the mechanisms behind patient resistance in oncology research.

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Get the